76 related articles for article (PubMed ID: 7535599)
1. Antibody pattern's lack of predictivity in determining the response of viral hepatitis C to interferon therapy.
Berardo C; Gerardi R; Delle Monache M; Del Vecchio S; Ricci GL
Ital J Gastroenterol; 1994; 26(8):398-400. PubMed ID: 7535599
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
Sakashita H
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
[TBL] [Abstract][Full Text] [Related]
3. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
10. Patterns of hepatitis C viremia in patients receiving hemodialysis.
Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
[TBL] [Abstract][Full Text] [Related]
11. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
[TBL] [Abstract][Full Text] [Related]
12. Therapy of hepatitis C: re-treatment with alpha interferon.
Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G
Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679
[TBL] [Abstract][Full Text] [Related]
13. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience.
Brillanti S; Miglioli M; Barbara L
J Hepatol; 1995; 23 Suppl 2():13-5; discussion 15-6. PubMed ID: 8720288
[TBL] [Abstract][Full Text] [Related]
14. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
[TBL] [Abstract][Full Text] [Related]
15. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
16. Comparison of treatment with two different doses of leukocyte interferon alpha in patients with chronic hepatitis C.
Laghi V; Toccaceli F; Rosati S; Monini A; Grimaldi M; Foglianti G; Canova N; Palazzini E
Hepatogastroenterology; 1997; 44(16):1182-6. PubMed ID: 9261621
[TBL] [Abstract][Full Text] [Related]
17. alpha-Interferon retreatment of patients with chronic hepatitis C.
Rabinovitz M; Block G; Finkelstein SD
Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
[TBL] [Abstract][Full Text] [Related]
20. The Oklahoma-Pittsburgh experience with interferon alpha in the treatment of HCV disease.
Van Thiel DH; Friedlander L; Fagiuoli S; Molloy P; Kania RJ; Wright H
J Okla State Med Assoc; 1995 Apr; 88(4):154-61. PubMed ID: 7782963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
